Device Trial Radar · NCT04090424
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
Last checked: Nov 19, 2026Latest source record: Feb 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Sep 21, 2021
Primary completion
May 30, 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- PolyNovo Biomaterials Pty Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Biomedical Advanced Research and Development Authority
- First posted
- Sep 16, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, pivotal study to assess the safety and effectiveness of a new method of treating severe burns using NovoSorb® Biodegradable Temporizing Matrix (BTM).
Conditions
- Burns
Interventions
NovoSorb BTMDevice
NovoSorb BTM comprises a completely synthetic, sterile, integrating dermal component (porous biodegradable polyurethane foam) and a temporary epidermal barrier component (a nonbiodegradable polyurethane sealing membrane). These layers are adhered with a biodegradable polyurethane bonding layer. BTM will be implanted and fixed into position to close a debrided burn wound. After a period of integration, the sealing membrane is removed and a split skin graft is applied.
Standard of CareProcedure
Burn wounds will be treated using the institution's standard of care, e.g. primary skin grafting, cadaveric allograft followed by skin grafting.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of study lesions in both groups with complete wound closure after skin graftingTime frame: 4 weeks after skin grafting
Locations
26 sites in 2 countries. Site status is shown where the registry gives one.
Valleywise Health
Phoenix, Arizona
Southern California Regional Burn Center at LAC+USC
Los Angeles, California
University of California Davis Medical Center
Sacramento, California
23 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.